Frequencies of symmetrical and asymmetrical exchange aberrations induced by two inhibitors of topoisomerase II, namely, 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) and etoposide (VP16), were estimated in human peripheral blood lymphocytes. The aberrations were scored using conventional Giemsa staining and fluorescence in situ hybridization (FISH) techniques, using chromosomespecific DNA libraries. Stable aberrations (translocations) were detected using two cocktails of DNA libraries specific for three chromosomes, namely 1, 3 and X and 2, 4 and 8, representing ~40% of the whole human genome. The frequencies of dicentrics and translocations increased in a dose-dependent manner, however, m-AMSA was found to be a more potent inducer of chromosomal aberrations in comparison with VP16 (at concentrations at which comparable frequencies of aberrations were induced) by 20-to 30-fold. When corrected for DNA content of chromosomes in each cocktail, a higher frequency of translocations with the cocktail consisting of chromosomes 2, 4 and 8 in comparison with 1, 3 and X was evident The genomic translocation frequency calculated from chromosome painting analysis for m-AMSA exceeded that estimated for dicentrics by ~2-fold. However, for VP16 almost equal frequencies of both types of chromosome exchange were found.
Introduction
Environmental and occupational exposure of man to genotoxic agents is a major risk factor in carcinogenesis. Estimation of the level of exposure is a important parameter for the determination of possible deleterious health effects. In most studies with human peripheral blood lymphocytes the frequency of chromosomal aberrations, especially dicentrics, is used as the biological end point. For ionizing radiation this has been used since the 1960s to estimate exposure dose (Bender and Gooch, 1966; Buckton et ai, 1967) . Following exposure to genotoxic chemicals such as vinyl chloride, styrene or benzene, quantification of chromosomal aberrations has also been used as a biomarker. Evidence that elevated frequencies of chromosomal aberrations in peripheral blood lymphocytes can predict an increased cancer risk is provided by the reports of the Nordic cohort study of cancer incidence and its correlation with chromosomal aberrations, sister chromatid exchange and micronuclei frequencies. The chromosomal aberration frequencies were found to be most closely correlated with cancer incidence in comparison with other two assays (Hagmar et ai, 1994) .
Generally, the majority of observed chromosomal aberrations in Giemsa stained preparations are dicentrics, rings and acentric fragments which are unstable aberrations and will lead to cell death during proliferation. Therefore, cells containing these types of aberrations decrease with post-exposure time. Balanced symmetrical chromosome exchanges (translocations) may persist for a longer time and therefore can provide an estimate of cumulative frequencies of chromosome aberrations. From the human point of view, stable aberrations such as translocations are very important, since they are associated with congenital abnormalities in newborns as well as in neoplasms of humans (Mitelman etal., 1991) . The introduction of the fluorescent in situ hybridization (FISH) technique with chromosome-specific composite DNA probes (Pinkel et ai, 1986; Lichter et ai, 1988; Natarajan et ai, 1991 Natarajan et ai, , 1992 has opened up the possibility of accurately and rapidly detecting numerical and structural chromosome aberrations.
When human lymphocytes are irradiated in vitro with Xrays and scored for the frequencies of dicentrics and (reciprocal, terminal and interstitial) translocations using FISH and chromosome-specific DNA probes, it has been found that the frequency of translocations is 1.5-3 times greater than dicentrics (Cremer et ai, 1990; Natarajan et ai, 1992; Schmid et ai, 1992; Bauchinger et ai, 1993; Tucker et ai, 1993) . For the radiomimetic and chemotherapeutic agent bleomycin the frequency of symmetrical exchanges was also higher (~2.5-fold) than asymmetrical ones (Hoffmann et ai, 1994; Ellard, et ai, 1995) .
At present, for screening and evaluation Giemsa stained preparations are used to detect potential carcinogens, by analysing predominantly chromatid exchanges and breaks, because most of the chemicals act in a S-dependent way.
The two inhibitors of topoisomerase II 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) and etoposide (VP16) are reported to act like S-independent agents (i.e. ionizing radiation), leading to induction of chromatid and chromosometype aberrations following treatment in Gj and G\ respectively in Chinese hamster ovary cells (CHO wild type and xrs mutant) and human lymphocytes (Andersson and Kihlman, 1989; Darroudi and Natarajan, 1989) .
Furthermore, it appears that anti-topoisomerase-induced DNA strand breaks are not resealed by the normal repair pathways (Zwelling and Mattem, 1982; Zwelling et ai, 1982) . While arabinofuranosylcytosine (ara-C) post-treatment strongly enhances the frequency of chromosome-type aberrations induced by X-rays (Preston, 1980) , it does not affect the frequency in m-AMSA-treated G o or Gi lymphocytes (Andersson and Kihlman, 1989) , pointing to a difference in the processing of induced strand breaks by these two agents. In the present paper the relative frequencies of symmetrical and asymmetrical chromosome exchanges induced in GQ human peripheral lymphocytes treated in vitro with two chemotherapeutic drugs, m-AMSA and VP-16, inhibitors of DNA topoisomerase II, were estimated.
The frequencies of chromosome exchanges, i.e. dicentrics and translocations, following Giemsa staining and chromosome painting techniques respectively were determined. A comparison was made between different types of aberrations induced by these two chemicals.
Materials and methods

Cell culture and treatment conditions
A whole blood sample was collected from a healthy male donor in a heparinized tube and cultured in Ham's F-10 medium supplemented with 20% fetal calf serum (heat inactivated at 56°Q, 100 IU/ml penicillin, 100 ug/ml streptomycin, 0.4 mM L-glutamine and 1% phytohaemagglutinin (PHA) (HA 15; Wellcome). Each culture consisted of 4.5 ml complete growth medium and 0.5 ml whole blood.
Lymphocytes in Go were exposed for 2 h to different doses of m-AMSA and VP16 at 37°C in Ham's F-10 medium without PHA. They were washed twice with pre-warmed F-10 medium and allowed to recover in complete medium with PHA. Three hours after stimulation the medium was removed by washing twice with F-10 and the cells allowed to grow in complete medium without PHA for a further 46 h. For the last 3 h cultures received colcemid at a final concentration of 0.2 (ig/ml. The removal of medium 3 h after stimulation was done in order to avoid induction of chromatid-type aberrations (Andersson and Kihlman, 1989) . On the basis of our previous findings, this protocol is expected to give >90% of cells in the first cell cycle. The preparation of slides was carried out by a conventional method. Slides to be scored for the presence of dicentrics were stained with aqueous Giemsa solution. Slides for in situ hybridisation were stored dry at -20°C until processed for hybridization.
Test chemicals m-AMSA was kindly provided by Dr D.De Marini (Environmental Protection
Agency, Genetic Toxicology Division, Research Triangle Part, NC). VP16 was purchased from Bristol Italia. Both chemicals were dissolved in dimethylsulphoxide (DMSO) (Fluka AG, Buchs, Switzerland). The final concentration of DMSO never exceeded 1% in the culture medium.
In situ hybridization
Bluescribe DNA libraries specific for chromosomes 1, 2, 3, 4 and X were labelled and used in two cocktails of DNA probes, three chromosomes in each (i.e. 1, 3 and X and 2, 4 and 8), representing in total ~40% of the human genome (Mendelsohn et ai, 1973) .
The in situ hybridization method as described by Pinkel et al. (1986) and Lichter et al. (1988) was used. Briefly, under standard conditions 10-30 u.g/ ml biotin-labelled DNA representing library inserts were combined with competitive DNA, ethanol precipitated and resuspended in 50% formamide, 2X SSC, 9% dextran sulphate, 40 mM phosphate buffer, pH 7.0, denatured at 70°C for 5 min and hybridized in situ (overnight at 37°C) with the cytological preparation. After hybridization the slides were washed in 50% formamide, 2X SSC, pH 7.0, for 4X5 min at 42°C followed by washes in 0.1X SSC for 3X5 min at 62°C and a final wash with 4X SSC, 0.005% Tween 20, pH 7.0, for 5 min.
The slides were then incubated with 5% natural non-fat dry milk for 15 min in a moist chamber at room temperature. Detection of the biotinylated probe was achieved using fluorescein-labelled avidin. All detection agents were incubated with 5 ng/ml fluorescein isothiocyanate conjugated with avidin D (Vector Laboratories) for 30 min at room temperature followed by three washes. Amplification of the signals was by reincubation with 5 (Xg/ml biotinconjugated anti-avidin D antibodies (Vector Laboratories) for 30 min at room temperature followed by another incubation with avidin D and FTTC for 30 min at room temperature. The signals were amplified twice, slides were dehydrated, dried and mounted in 20 mM Tris-HCl, pH 7.5, 90% glycerol containing 2% antifade [4',6-diamidino-2-phenylindole (DAPI); Serva].
Preparations were examined under a Zeiss microscope equipped with DAPI and FTTC epifluorescence optics or an Omega triple filter.
Scoring criteria
Dicentrics were scored in Giemsa stained preparations. Except for the dose of 1 \iM m-AMSA, for which 200 cells were analysed, for the other doses the analysis was carried out in 800 metaphases.
To detect chromosomal translocations following single colour in situ hybridization a total of 400-700 metaphases were analysed.
The classification of normal or aberrant chromosomes was based on the characteristic painting patterns in combination with the size and morphology of the chromosomes identified via DAPI counterstaining. All types of translocations (i.e. reciprocal, terminal and interstitial) were observed and included in the analysis. DAPI was used as the counterstain as it has the advantage of intensifying the centromeric signal, therefore, the position of the centromere was clearly visible and it was possible to discriminate between dicentrics and translocations.
The frequency of translocation for the whole genome was estimated based on the DNA content of chromosomes involved in each cocktail. The cocktail of 1, 3 and X represents 19.6% of the human genome and that of 2, 4 and 8 represents 18.9%. The frequency of translocation for the whole genome was calculated for each cocktail separately and compared with the others. Finally the mean value was estimated and used for comparison with dicentric frequency obtained for the whole genome in Giemsa stained preparations.
Results
The results obtained using classical cytogenetic analysis in Giemsa stained preparations are presented in Table I .
Following treatment with m-AMSA and VP16 the frequencies of chromosome-type aberrations (i.e. dicentrics, rings and acentric fragments) increased in a dose-dependent manner in human lymphocytes. Most of the dicentrics were accompanied by one acentric fragment and tricentrics with two fragments. However, for m-AMSA 2-7% and for VP16 6% of dientrics were found to have no accompaning acentric fragment, the fragment having possibly joined to other chromosomes as a terminal translocation (Table II) which could not be detected using the Giemsa staining technique.
For m-AMSA and VP16 the frequency of chromatid-type aberrations did not exceed 3 and 1% respectively. The present data confirm the previous findings that m-AMSA and VP16-induced chromosomal aberrations are formed by an S phaseindependent mechanism (Deaven et al, 1978; Andersson and Kihlman, 1989; Darroudi and Natarajan, 1989) . Table II shows the types and frequencies of stable aberrations, such as interstitial (IT), reciprocal (RT) and terminal translocations (TT), for each cocktail as detected following single colour in situ hybridization (FISH). The frequency of aberrant cells and total translocations per genome are also reported. In this study two cocktails of DNA probes specific for chromosomes 1, 3 and X and 2, 4 and 8 were used. Terminal and reciprocal translocations were the main types of aberrations observed (Table II) . However, it should be added that some of these translocations scored as terminals could have been cryptic reciprocal, which could depend on the resolution of the FISH assay employed.
Translocation frequencies increased in a dose-dependent manner for both chemicals (Table IT) .
The results obtained show that m-AMSA is more genotoxic on the basis of the induced frequencies of symmetrical and asymmetrical aberrations, when compared with VP16, by a factor of 20-30. The comparison was made on the basis of the concentration (molarity) at which an equal number of aberrations was induced.
For m-AMSA the translocation frequencies were ~2.7-, 4.3-, 1.8-and 1.5-fold higher than the frequencies of dicentrics at dose levels of 1, 5, 7.5 and 10 (xM respectively (Tables I  and II) . However, following VP16 treatment the frequencies of translocations and dicentrics were similar, i.e. 1.6-, 0.7-and 1.0-fold at dose levels of 50, 100 and 200 |iM respectively (Tables I and II) .
The frequencies of induced translocations involving chromo- somes 2, 4 and 8 were 20-30% higher than 1, 3 and X (corrected for DNA content).
Chromosomal aberrations and topolsomerase II Inhibitors
Using two cocktails consisting of six pairs of chromosomes no evidence for aneuploidy was found following treatment with m-AMSA and VP 16.
Discussion
In the present study m-AMSA and VP16 were found to induce symmetrical and asymmetrical exchanges in human peripheral blood lymphocytes in a dose-dependent manner. In m-AMSAtreated G o lymphocytes a higher frequency of translocations (using FISH) in comparison with dicentrics detected by conventional Giemsa staining was evident. For VP16 the induced frequencies of dicentrics and translocations were found to be similar. In addition, a higher sensitivity of lymphocytes to the genotoxic effect of m-AMSA was observed, i.e. ~20-to 30-fold in comparison with VP16 (Tables I and II) .
m-AMSA and VP16 are used as anti-cancer drugs for different types of tumours, i.e. central nervous system tumours (Holm et al, 1996) and leukemias (Gorczyca et al, 1993) . They have been shown to induce DNA double-strand breaks and chromosomal aberrations in CHO cells and human lymphocytes (Andersson and Kihlman, 1989; Darroudi and Natarajan, 1989) . This has been shown to be closely associated with stabilization of the cleavage complex (Suzuki et al, 1995) . The breaks induced by both drugs are formed by an enzymemediated process, in contrast to DSBs produced by ionizing radiation, which are protein concealed and can only be detected by DNA filter elution if the cell lysates are digested with a proteinase before elution (Zwelling et al, 1981; Zwelling 1985; Glisson and Ross, 1987) . Furthermore, it appears that anti-topoisomerase-induced DNA breaks are not resealed by normal repair pathways (Zweling and Mattem, 1982; Zwelling et al, 1982) .
Topoisomerase II (topo II) enzymes are involved in the maintenance of DNA structure, removing torsional stresses that occur in double-strand DNA during both transcription and replication. Topo II causes transient breaks in both strands of the DNA allowing passage of one double helix through another. m-AMSA and VP16 are thought to act on topo II enzymes to stabilize the DNA-drug-topo II complex known as the 'cleavage complex'. Therefore, these anti-topoisomerase drugs do not prevent cleavage of DNA but inhibit religation. This type of lesion differs from the covalent lesions associated with alkylating agents in its reversibility, as they disappear upon removal of the drug.
P.Mosesso et at
Anti-topoisomerase drugs belonging to different chemical classes induce different amounts of DNA breaks at equitoxic concentrations (Zwelling et al, 1981 (Zwelling et al, , 1982 . This could be easily explained by differences in the kinetics of DNA break formation and repair (Zwelling et al, 1981) and in the DNA site specificity of topo II following interactions with these inhibitors (Rowe et al, 1986) . Furthermore, the mode of action of DNA intercalating agents like m-AMSA, which binds noncovalently to DNA through insertion between adjacent base pairs, and 'non-intercalating' inhibitors of topo II like VP16 could also contribute to the observed differences. Thus, (i) the different modes of interaction of topo II inhibitors with DNA and (ii) induced frequencies, persistence and repair kinetics of the induced DNA lesions [i.e. single-strand breaks (SSB) and double-strand breaks (DSB)] that lead to formation of chromosomal alterations may be different between m-AMSA and VP16. Spiridonidis et al. (1989) reported that in V-79 cells at equitoxic doses of VP16 produced a DNA SSB frequency approximately equal to 1000 rad equivalents, while m-AMSA produced 3000 rad equivalents of DNA SSB.
In CHO wild-type (CHO-K1) and xrs mutants (xrs5 and xrs6) treated with m-AMSA and VP16 in the G 2 stage of the cell cycle a higher chromatid aberration frequency was found with m-AMSA in comparison with VP16 (~15-fold) in CHOKl cells. In xrs mutants, known to be deficient in repair of DNA DSBs, this ratio increased to ~75-fold (Darroudi and Natarajan, 1989) .
In conclusion, it can be stated that at the concentrations employed, following m-AMSA treatment a large proportion of induced DNA strands breaks remained open, later forming DSBs leading to formation of chromosome translocations. This means that there must be a mechanism by which chromosomal aberrations can be formed as a result of stabilization of the cleavage complex induced by m-AMSA. It could be due to an exchange between topo II subunits, leading to an illegitimate recombination event (Pommier et al, 1985; Bae et al, 1988) .
The observed differences between the translocation:dicentric ratios are very interesting and worth investigating further. It has been shown that by altering the irradiation conditions or the recovery of irradiated lymphocytes one can modify the translocation:dicentric ratio (Natarajan et al, 1997) .
